- Home
- ATHA vs RAY Comparison
ATHA vs RAY Comparison
Compare ATHA & RAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- RAY
- Stock Information
- Founded
- ATHA 2011
- RAY 1993
- Country
- ATHA United States
- RAY Hong Kong
- Employees
- ATHA N/A
- RAY N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- RAY Consumer Electronics/Appliances
- Sector
- ATHA Health Care
- RAY Consumer Discretionary
- Exchange
- ATHA Nasdaq
- RAY Nasdaq
- Market Cap
- ATHA 21.0M
- RAY 24.7M
- IPO Year
- ATHA 2020
- RAY 2024
- Fundamental
- Price
- ATHA $0.53
- RAY $1.20
- Analyst Decision
- ATHA Buy
- RAY
- Analyst Count
- ATHA 4
- RAY 0
- Target Price
- ATHA $11.25
- RAY N/A
- AVG Volume (30 Days)
- ATHA 235.4K
- RAY 371.3K
- Earning Date
- ATHA 02-20-2025
- RAY 02-20-2025
- Dividend Yield
- ATHA N/A
- RAY N/A
- EPS Growth
- ATHA N/A
- RAY N/A
- EPS
- ATHA N/A
- RAY 0.06
- Revenue
- ATHA N/A
- RAY $9,936,869.00
- Revenue This Year
- ATHA N/A
- RAY N/A
- Revenue Next Year
- ATHA N/A
- RAY N/A
- P/E Ratio
- ATHA N/A
- RAY $18.93
- Revenue Growth
- ATHA N/A
- RAY 28.52
- 52 Week Low
- ATHA $0.41
- RAY $1.09
- 52 Week High
- ATHA $4.30
- RAY $6.04
- Technical
- Relative Strength Index (RSI)
- ATHA 41.88
- RAY N/A
- Support Level
- ATHA $0.52
- RAY N/A
- Resistance Level
- ATHA $0.57
- RAY N/A
- Average True Range (ATR)
- ATHA 0.04
- RAY 0.00
- MACD
- ATHA -0.00
- RAY 0.00
- Stochastic Oscillator
- ATHA 11.82
- RAY 0.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About RAY Raytech Holding Limited Ordinary Shares
Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.